International Stakeholder Engagement on Clinical Care and Research for Sleep Assessment and Nocturnal Hypoxemia in Pulmonary Fibrosis
CHEST · 2025
DOI: 10.1016/j.chest.2025.09.020 ↗Kurz gefasst
Fachartikel in der Zeitschrift CHEST, 2025. Verfasst von Leona Dowman und 16 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Research@Alfred, School of Translational Medicine, Monash University, Melbourne, VIC, Australia; Department of Physiotherapy, Austin Heal…. Hauptthemen laut MEDLINE: Hypoxia, Pulmonary Fibrosis, Stakeholder Participation, Sleep. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical Research Future Fund, National Health and Medical Research Council, Lung Foundation Australia.
Abstract (Originalsprache)
BACKGROUND: Nocturnal hypoxemia commonly affects people with pulmonary fibrosis (PF). RESEARCH QUESTION: What are the current practices for assessment of sleep and nocturnal hypoxemia in PF, and what are the research priorities and outcome measures of importance for nocturnal oxygen therapy (NOT)? STUDY DESIGN AND METHODS: People with PF and health care professionals (HCPs) with expertise in PF, sleep medicine, and/or oxygen therapy, were recruited internationally to participate in mixed-methods online surveys followed by online focus groups. RESULTS: A total of 68 people with PF and 73 HCPs from 29 countries completed the survey, with 14 and 39 joining the focus groups, respectively. Of these, 51% of people with PF had previous sleep assessment. In those that had not, 75% advocated its inclusion in routine PF management. Of HCPs, 64% performed sleep assessments routinely or as clinically indicated, with 82% reporting the assessments as very or somewhat important. The effect of treating nocturnal hypoxemia on symptom burden (including health-related quality of life) was considered the top research priority for people with PF and HCPs. Other research priorities identified were safety and tolerability of NOT, effect of treating nocturnal hypoxemia on mortality and pulmonary hypertension, diagnostic approaches for assessing sleep and nocturnal hypoxemia, predictors of nocturnal hypoxemia, developing a user-friendly oxygen therapy device, and patient awareness of the significance of nocturnal hypoxemia. Both groups prioritized health-related quality of life as the most important outcome measure for evaluating NOT. Additionally, people with PF highly ranked FVC, apnea-hypopnea index, and nocturnal oxygenation status, whereas HCPs selected survival and development of pulmonary hypertension. People with PF raised impact of nocturnal hypoxemia and sleep disturbance on cognitive performance as a key research topic, which was agreed by HCPs. INTERPRETATION: This study provides important insights into stakeholders' priorities to guide future research on sleep assessment and treatment of nocturnal hypoxemia in PF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Respiratory Research@Alfred, School of Translational Medicine, Monash University, Melbourne, VIC, Australia; Department of Physiotherapy, Austin Health, Melbourne, VIC, Australia; Institute for Breathing and Sleep, Heid…
- Department of Physiology, School of Biomedical Sciences and Biomedical Discovery Institute, Monash University, Alfred Health, Melbourne, VIC, Australia; School of Psychological Sciences, Monash University, Clayton, Alfr…
- Respiratory Research@Alfred, School of Translational Medicine, Monash University, Melbourne, VIC, Australia; Department of Respiratory and Sleep Medicine, Alfred Health, Melbourne, VIC, Australia.
- Centre of Excellence for ILD and Sarcoidosis, Department of Respiratory Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands.
- Department of Medicine, University of British Columbia; Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.
- Institute for Breathing and Sleep, Heidelberg, VIC, Australia; Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, VIC, Australia; Faculty of Medicine, Dentistry and Health Sciences, The University…
Förderung
- Medical Research Future Fund
- National Health and Medical Research Council
- Lung Foundation Australia
Zitieren
APA
Dowman, L., Landry, S., Smallwood, N., Moor, C., Edwards, B. A., Ryerson, C. J., McDonald, C. F., Goh, N. S., Patsamanis, H., Cochrane, L., Joosten, S., Wijsenbeek, M., Ekström, M., Moreno, S. V., Hepworth, G., Holland, A. E., & Khor, Y. H. (2025). International Stakeholder Engagement on Clinical Care and Research for Sleep Assessment and Nocturnal Hypoxemia in Pulmonary Fibrosis. CHEST. https://doi.org/10.1016/j.chest.2025.09.020
Vancouver
Dowman L, Landry S, Smallwood N, Moor C, Edwards BA, Ryerson CJ, et al. International Stakeholder Engagement on Clinical Care and Research for Sleep Assessment and Nocturnal Hypoxemia in Pulmonary Fibrosis. CHEST. 2025. doi:10.1016/j.chest.2025.09.020
BibTeX
@article{Dowman2025,
author = {Dowman, Leona and Landry, Shane and Smallwood, Natasha and Moor, Catharina and Edwards, Bradley A and Ryerson, Christopher J and McDonald, Christine F and Goh, Nicole S and Patsamanis, Harry and Cochrane, Lynne and Joosten, Simon and Wijsenbeek, Marlies and Ekström, Magnus and Moreno, Sebastian V and Hepworth, Graham and Holland, Anne E and Khor, Yet H},
title = {International Stakeholder Engagement on Clinical Care and Research for Sleep Assessment and Nocturnal Hypoxemia in Pulmonary Fibrosis},
journal = {CHEST},
year = {2025},
doi = {10.1016/j.chest.2025.09.020}
}
EUVIMED